CoChat

Fine Mapping of Genetic Variants in BIN1, CLU, CR1 and PICALM for Association with Cerebrospinal Fluid Biomarkers for Alzheimer's Disease

Kauwe, John S. K., Cruchaga, Carlos, Karch, Celeste M., Sadler, Brooke, Lee, Mo, Mayo, Kevin, Latu, Wayne, Su'a, Manti, Fagan, Anne M., Holtzman, David M., Morris, John C., Alzheimer's Disease Neuroimaging Initiative, Goate, Alison M. · 2011 · PLoS ONE
Cited by 66

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Recent genome-wide association studies of Alzheimer's disease (AD) have identified variants in BIN1, CLU, CR1 and PICALM that show replicable association with risk for disease. We have thoroughly sampled common variation in these genes, genotyping 355 variants in over 600 individuals for whom measurements of two AD biomarkers, cerebrospinal fluid (CSF) 42 amino acid amyloid beta fragments (Aβ(42)) and tau phosphorylated at threonine 181 (ptau(181)), have been obtained. Association analyses were performed to determine whether variants in BIN1, CLU, CR1 or PICALM are associated with changes in the CSF levels of these biomarkers. Despite adequate power to detect effects as small as a 1.05 fold difference, we have failed to detect evidence for association between SNPs in these genes and CSF Aβ(42) or ptau(181) levels in our sample. Our results suggest that these variants do not affect risk via a mechanism that results in a strong additive effect on CSF levels of Aβ(42) or ptau(181).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0015918

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 10

  1. G Jun, 2010, Meta-analysis Confirms CR1, CLU, and PICALM as Alzheimer Disease Risk Loci and Reveals Interactions With APOE Genotypes., 10.1001/archneurol.2010.201 · DOI · Paper page
  2. JC Lambert, 2009, Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease., Nat Genet, 41, 1094, 10.1038/ng.439 · DOI · Paper page
  3. P Wigge, 1997, Amphiphysin heterodimers: potential role in clathrin-mediated endocytosis., Mol Biol Cell, 8, 2003, 10.1091/mbc.8.10.2003 · DOI · Paper page
  4. E Masliah, 2001, Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease., Neurology, 56, 127, 10.1212/WNL.56.1.127 · DOI · Paper page
  5. JS Kauwe, 2008, Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition., Proc Natl Acad Sci U S A, 105, 8050, 10.1073/pnas.0801227105 · DOI · Paper page
  6. JL Price, 1999, Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease., Ann Neurol, 45, 358, 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X · doi:10.1002/1531-8249(199903)45:3<358::aid-ana12>3.0.co;2-x
  7. S Purcell, 2007, PLINK: a tool set for whole-genome association and population-based linkage analyses., Am J Hum Genet, 81, 559, 10.1086/519795 · DOI · Paper page
  8. L McLaughlin, 2000, Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis., J Clin Invest, 106, 1105, 10.1172/JCI9037 · DOI · Paper page
  9. M Jozsi, 2002, Complement receptor type 1 (CD35) mediates inhibitory signals in human B lymphocytes., J Immunol, 168, 2782, 10.4049/jimmunol.168.6.2782 · DOI · Paper page
  10. L Jones, 2010, Genetic evidence for the involvement of lipid metabolism in Alzheimer's disease., Biochim Biophys Acta, 1801, 754, 10.1016/j.bbalip.2010.04.005 · DOI

Cited by

See all 66

Metadata

Authors
Kauwe, J. S. K., Cruchaga, C., Karch, C. M., Sadler, B., Lee, M., Mayo, K., Latu, W., Su'a, M., Fagan, A. M., Holtzman, D. M., Morris, J. C., Initiative, A. D. N., & Goate, A. M.
Venue
PLoS ONE
Published
2011-02-09
Volume
6
Issue
2
Pages
e15918
ISSN
1932-6203
Cited by
66
References
16
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.